eCARTv5 Clinical Deterioration Suite (eCART) vs Lumiata AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Lumiata AI

by Lumiata

AI Verdict

While both tools leverage AI for predictive analytics in healthcare, eCARTv5 focuses specifically on real-time clinical deterioration prediction and guidance for hospitalized adult patients. Lumiata AI, on the other hand, offers a broader platform for identifying high-risk patients across various conditions and managing costs, making it more suitable for population health and chronic disease management. Therefore, eCARTv5 is ideal for acute care settings, while Lumiata AI is better suited for broader predictive analytics and population health initiatives.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an FDA-cleared, AI-powered solution for continuous, real-time monitoring of hospitalized adult patients to predict clinical deterioration (death or ICU transfer). It's ideal for integrating directly into existing EHR workflows, providing early warnings and guiding clinical staff with embedded pathways to facilitate timely interventions and reduce clinician workload.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Lumiata AI if…

Choose Lumiata AI if your healthcare organization requires a robust AI-driven predictive analytics platform for identifying high-risk patients, managing costs, and enabling proactive, personalized care across a population. It is well-suited for synthesizing diverse patient data into comprehensive health records, enriching data with proprietary disease codes, and utilizing pre-trained or custom AI models to predict chronic conditions and financial risks.

View Lumiata AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Lumiata AI
Pricing	Contact vendor for tailored quote.	Subscription-based
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based, On-premises options available for enterprise environments
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Unknown
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 is designed for direct integration into EHR systems with embedded clinical pathways, suggesting a seamless workflow for clinicians. Lumiata AI, while powerful, focuses more on an analytics platform and model building, which might require more specialized user interaction.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 is an FDA-cleared SaMD specifically designed to predict clinical deterioration (death or ICU transfer) and guide care with early warnings and pathways. Lumiata AI offers broader predictive analytics for risk identification and cost management, but eCART's direct impact on acute patient outcomes and regulatory clearance gives it an edge in immediate clinical value.

Pricing & Value

Tie

Both tools require contacting the vendor for specific pricing, making a direct comparison difficult. eCARTv5 offers a clear value proposition in reducing critical events, while Lumiata AI provides value through broader population health and cost management. Without transparent pricing, it's impossible to determine which offers better value.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. eCARTv5 integrates with EHRs and offers reporting capabilities, while Lumiata AI provides both cloud and on-premises deployment options, HIPAA compliance, and BAA, catering to diverse enterprise needs. Both are designed for large-scale healthcare environments.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5's FDA clearance as an AI-powered SaMD for continuous, real-time clinical deterioration prediction with embedded pathways represents significant innovation in acute care. While Lumiata AI's platform for building and deploying custom models is innovative, eCART's specific application and regulatory status highlight its cutting-edge approach to patient safety.

Support & Docs

Tie

Neither product's provided information details specific support structures or documentation availability. While both are enterprise-grade solutions, implying robust support, there's no basis to differentiate between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Lumiata AI
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	Lumiata AI
Company	AgileMD	Lumiata
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	AI-driven predictive analytics and pre-trained models to identify high-risk patients, manage costs, and enable proactive interventions and personalized care.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	AI Platform for data ingestion, cleansing, and organization, Synthesis of patient data into comprehensive historical health records, Proprietary Lumiata Disease Codes for data enrichment, Pre-trained AI models for various healthcare use cases, Lumiata AI Studio for building and deploying machine learning models, Predictive analytics for chronic conditions (e.g., diabetes, CKD, CHF), Risk Matrix for individual and population-level risk predictions, Integration with existing data analytic tools (e.g., Tableau)

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Lumiata AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and fit into current clinical workflows?

eCARTv5 is designed for direct EHR integration, analyzing up to 97 real-time variables from sources like vital signs and lab results to provide continuous patient risk assessment and guide care with embedded clinical pathways. Lumiata AI, on the other hand, integrates with existing data analytic tools and can harmonize various datasets, including claims and EHR data, using the FHIR standard, allowing its predictive insights to be incorporated into diverse user workflows and information systems.

What is the accuracy and sensitivity of each tool in predicting patient outcomes?

eCARTv5 has demonstrated high accuracy in identifying clinical deterioration, with an AUROC of 0.834 in retrospective validation and consistent performance across diverse patient demographics and conditions. It aims to maximize early identification of at-risk patients while minimizing false alarms. Lumiata's predictive models are built from over 100 million patient records and in-depth clinical knowledge, with validation studies showing 95% concordance with the Emergency Severity Index.

What is the typical learning curve for physicians and clinical staff to effectively use each tool?

eCARTv5 is designed with an intuitive user interface and well-tested clinical workflow to minimize false alarms and decrease clinician workload, suggesting a focus on ease of use within existing clinical processes. Lumiata AI aims to make data accessible for business analysts and non-technical users through conversational analytics, allowing them to explore data and generate insights without extensive technical expertise, which could indicate a lower learning curve for basic use.

What kind of support and resources are available for implementation and ongoing use?

While specific details on support quality are not provided for eCARTv5, AgileMD emphasizes that its clinical pathways integrate seamlessly with native EHR workflows and can be deployed quickly without heavy reliance on IT support. Lumiata offers pre-trained AI models and the Lumiata AI Studio for building and deploying machine learning models, suggesting resources for data science teams, and also partners with companies like Ascend.io to enhance data preparation and access.

Beyond HIPAA, what additional security measures and audit-trail features do these tools offer?

Lumiata AI emphasizes enterprise-grade security with SOC 2 compliance, granular role-based access control (RBAC), secure authentication with SSO and MFA support, and audit logs that track data access and administrative actions. It also states that data never leaves the customer environment, with all processing performed in-place. For eCARTv5, while HIPAA compliance is stated, further details on security posture beyond HIPAA and specific audit-trail features are not explicitly provided in the given information.

How do these tools support multi-site rollouts and ensure consistent performance across different hospital environments?

eCARTv5's FDA clearance was based on clinical performance data from nearly two million hospitalizations across 21 hospitals, including real-world prospective data, ensuring consistent accuracy across geography, age, race, and medical conditions, which suggests its suitability for multi-site rollouts. Lumiata's platform is described as scalable and able to integrate with existing systems through APIs, and it works with various healthcare organizations, indicating its adaptability for different environments.